Home

Canopy Growth Corporation - Common Shares (CGC)

2.0300
-0.0700 (-3.33%)

Canopy Growth Corp is a leading player in the cannabis industry, focusing on the production and distribution of a wide range of cannabis products

The company is engaged in cultivating and processing cannabis for both medical and recreational purposes, offering various forms such as dried flower, oils, edibles, and beverages. With a commitment to innovation, Canopy Growth invests in research and development to create high-quality products that meet consumer demands and adhere to evolving regulations. The company also emphasizes sustainability and responsible business practices, aiming to shape the future of cannabis consumption and enhance the overall experience for consumers.

SummaryNewsPress ReleasesChartHistoricalFAQ
Previous Close2.100
Open2.100
Bid2.020
Ask2.030
Day's Range2.020 - 2.127
52 Week Range1.990 - 14.92
Volume1,581,255
Market Cap1.19B
PE Ratio (TTM)-0.3167
EPS (TTM)-6.4
Dividend & YieldN/A (N/A)
1 Month Average Volume5,372,730

News & Press Releases

Can Canada Maintain Its Cannabis Edge After Trudeau's Departure?benzinga.com
Trudeau's exit leaves Canada's cannabis industry at a crossroads. Will new leadership support its growth?
Via Benzinga · January 29, 2025
The Week In Cannabis: Trump's DEA Pick, Tyson's Reform Push, Dutch Coffee Shop Crisis And Morebenzinga.com
This week in cannabis: DEA shake-up, contaminated cannabis in the Netherlands, and global market updates.
Via Benzinga · January 24, 2025
Biden Commutes the Sentences of Almost 2,500 Inmates Convicted on Drug Offences
Former U.S. President Joe Biden commuted the sentences of almost 2,500 inmates convicted of various non-violent drug offenses ( including marijuana ) during his last days in the Oval Office. Biden noted that with this last round of commutations, he has granted clemency to more Americans than any other president in U.S. history.
Via CannabisNewsWire · January 23, 2025
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025benzinga.com
Via Benzinga · January 20, 2025
420 with CNW — Marijuana Industry Predictions for 2025
The marijuana industry experienced a sluggish pace of progress in 2024. Efforts to pass cannabis reform measures in Congress fell short, and the DEA delayed rescheduling cannabis as a recognized medicinal substance.
Via CannabisNewsWire · January 13, 2025
The Week In Cannabis: Tilray Earnings, NY Hits $1B In Sales, DoorDash Embraces Hemp, Ukraine And Morebenzinga.com
Cannabis news of the week: New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.
Via Benzinga · January 10, 2025
Cannabis Stock Movers For January 9, 2025benzinga.com
Via Benzinga · January 9, 2025
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags Onbenzinga.com
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Via Benzinga · January 8, 2025
EXCLUSIVE: Cannabis Physician Says Surgeon General's Alcohol Cancer Risk Warning Is 'Wake-Up Call'benzinga.com
Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.
Via Benzinga · January 3, 2025
Recent Scientific Findings Altering Our Knowledge about Marijuana
While around one in every five Americans now use marijuana, the understanding of its health effects has historically been limited . However, as regulations surrounding cannabis ease, scientists are gaining new insights into its benefits and risks.
Via CannabisNewsWire · December 26, 2024
Marijuana Users Spend Fewer Days in Hospital for Epilepsy, Study Finds
A new study has found that marijuana users with epilepsy typically spend fewer days in the hospital for epilepsy-related issues compared to people with epilepsy who didn’t use cannabis. Data from the study shows that epileptic individuals who used cannabis had an elevated epilepsy event capturability rate and reduced hospital stays.
Via CannabisNewsWire · December 13, 2024
EXCLUSIVE: Drug Expert Dr. Carl Hart Slams Cannabis Prohibition Amid Hemp-THC Surgebenzinga.com
Dr. Carl Hart discusses hemp THC, unregulated markets, and the need for federal cannabis legalization to reduce risks and protect consumers.
Via Benzinga · December 9, 2024
Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Knowbenzinga.com
Canopy USA, LLC has wrapped up its acquisition of Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF), Canopy Growth Corporation's (TSX: WEED) (NASDAQCGC) U.S.-domiciled holding company said on Monday. Canopy USA, created in 2022 to streamline the Canadian cannabis giant's entry into the US market, now owns 100% of the issued and outstanding shares of Acreage. The $3.4 billion acquisition deal was first in 2019. Initially, the deal was to be undertaken should the U.S. legalize marijuana on a federal level. That deal was later restructured.
Via Benzinga · December 9, 2024
420 with CNW — Federal Court Upholds Ban on Cannabis Advertising in Mississippi
Mississippi’s medical cannabis businesses are prohibited from advertising on billboards or any other platforms due to marijuana’s federal status as an illegal substance, according to a recent decision by an appeals court.
Via CannabisNewsWire · December 5, 2024
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demandbenzinga.com
Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Via Benzinga · December 5, 2024
Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?benzinga.com
In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.
Via Benzinga · December 5, 2024
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flowbenzinga.com
Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.
Via Benzinga · December 4, 2024
Canopy Growth Set To Complete Acreage Acquisition, Leaving Some Shareholders Potentially Open To Lossesbenzinga.com
Canopy Growth Corporation (TSX: WEED) (NASDAQCGC) and Acreage Holdings, Inc. (CSE: ACRG.A.U, ACRG.B.U)(OTCQX: ACRHF, ACRDF) announced on Monday that it is anticipated that Canopy USA, LLC will complete its acquisition of Acreage on or around Dec. 9, 2024. The Canadian cannabis giant announced its plans to acquire Acreage for $3.4 billion in 2019. Initially, the deal was to be undertaken should the U.S. legalize marijuana on a federal level. That deal was later restructured. The deal outlined the plan to acquire all Class E subordinate voting shares of Acreage. This acquisition will follow the purchase of the Class D shares of Acreage, based on an agreement from October 24, 2022. After both acquisitions are completed, Canopy USA will own all shares of Acreage.
Via Benzinga · December 3, 2024
Cannabis Retailer Tokyo Smoke Moves Forward After Major Restructuringbenzinga.com
Cannabis retailer Tokyo Smoke has finished its restructuring process and is no longer under financial protection, following a court's approval. The Canadian company first announced that it started restructuring its business in August, obtaining an initial order under the Companies Creditors Arrangement Act (CCAA) from the Ontario Superior Court of Justice in Canada. In Sept. the company entered a share subscription agreement with TS Investments Corp., its parent company. Under the deal, TS Investments agreed to subscribe to all of the issued and outstanding shares of Tokyo Smoke. That deal was valued at roughly $56.7 million (CA$77 million).
Via Benzinga · December 2, 2024
Flora Growth Taps Europe's CBD Boom With $500K Czech-Slovak Partnership Renewalbenzinga.com
Via Benzinga · November 27, 2024
Canopy USA's Acquisition Of Acreage Could Mean Staggering Losses For Some Shareholdersbenzinga.com
Acreage Holdings, Inc. (CSE:ACRG.A.U, ACRG.B.U) (OTCQX: ACRHF, ACRDF) said it anticipates that Canopy USA, LLC -Canopy Growth Corporation‘s (TSX: WEED) (NASDAQCGC) strategy for capturing the U.S. cannabis - will complete its acquisition of Acreage by mid-December, 2024.The move could leave holders of Acreage's Class E shares (fixed shares) with nothing. That is, if Canopy's stock price price remains below $5 when the deal closes, Acreage said in Monday's press release.
Via Benzinga · November 26, 2024
Aurora Cannabis Stock Analysis: Key Levels And Trading Opportunitiesbenzinga.com
Aurora Cannabis (NASDAQACB) stock finds support at $4.16 amid Fibonacci analysis and bullish divergence. Learn key levels for traders.
Via Benzinga · November 26, 2024
The Canadian Cannabis Report - Monday, Nov 25talkmarkets.com
The past, present and future of the Canadian cannabis sector
Via Talk Markets · November 25, 2024
Canopy Growth Names New CEO Who Will Succeed David Klein Amid US Expansionbenzinga.com
Canopy Growth Corporation (TSX: WEED) (NASDAQCGC) announced on Tuesday its board of directors has named Luc Mongeau as the company's next chief executive officer, effective Jan. 6, 2025.Mongeau, a CPG veteran and current board member at the Canadian cannabis giant, succeeds CEO David Klein, who announced his plans to retire in August.Klein, who joined Canopy Growth in January 2020, led the Ontario-based company through transformation and development to meet opportunities within the global cannabis market.
Via Benzinga · November 26, 2024
Canopy Growth's German Subsidiary Teams Up With Portugal's Gro-Vida To Expand Medical Cannabis Supplybenzinga.com
Via Benzinga · November 25, 2024